TrialObesity (Silver Spring, Md.)2025

Effect of semaglutide 2.4 mg on use of antihypertensive and lipid-lowering treatment in five randomized controlled STEP trials.

Beverly G Tchang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.